Skip to main content
PMC home page
Gut logoLink to Gut
. 1992 May;33(5):663–667. doi: 10.1136/gut.33.5.663

DNA aneuploidy in Crohn's disease and ulcerative colitis: results of a comparative flow cytometric study.

R Porschen 1, U Robin 1, A Schumacher 1, S Schauseil 1, F Borchard 1, K J Hengels 1, G Strohmeyer 1
PMCID: PMC1379298  PMID: 1612484

Abstract

DNA ploidy and S-phase fractions were assessed by flow cytometry in colonic biopsy specimens from 28 patients with ulcerative colitis and 51 with Crohn's disease. Whereas only diploid DNA histograms were found in Crohn's disease and control subjects, three patients with ulcerative colitis exhibited DNA aneuploidy. In one case, aneuploidy was associated with low grade dysplasia. S-phase fractions were higher in ulcerative colitis (mean (SD) 17.8 (7.7)%) than in Crohn's disease (13.1 (4.6)%) or control subjects (14.2 (4.6)%), but did not correlate with either disease activity or duration in any group. In this study, aneuploidy was associated exclusively with ulcerative colitis, even in the absence of dysplasia. In view of the epidemiological differences in malignant colonic transformation between ulcerative colitis and Crohn's disease, this study suggests that flow cytometry may help to identify individuals with an increased cancer risk in ulcerative colitis.

Full text

PDF
663

Images in this article

664Figure 1
on p.664

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allan A., Bristol J. B., Williamson R. C. Crypt cell production rate in ulcerative proctocolitis: differential increments in remission and relapse. Gut. 1985 Oct;26(10):999–1003. doi: 10.1136/gut.26.10.999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Broström O., Löfberg R., Nordenvall B., Ost A., Hellers G. The risk of colorectal cancer in ulcerative colitis. An epidemiologic study. Scand J Gastroenterol. 1987 Dec;22(10):1193–1199. doi: 10.3109/00365528708996463. [DOI] [PubMed] [Google Scholar]
  3. Cheng H., Bjerknes M., Amar J. Methods for the determination of epithelial cell kinetic parameters of human colonic epithelium isolated from surgical and biopsy specimens. Gastroenterology. 1984 Jan;86(1):78–85. [PubMed] [Google Scholar]
  4. Dean P. N. A simplified method of DNA distribution analysis. Cell Tissue Kinet. 1980 May;13(3):299–308. doi: 10.1111/j.1365-2184.1980.tb00468.x. [DOI] [PubMed] [Google Scholar]
  5. Deschner E. E., Winawer S. J., Katz S., Katzka I., Kahn E. Proliferative defects in ulcerative colitis patients. Cancer Invest. 1983;1(1):41–47. doi: 10.3109/07357908309040931. [DOI] [PubMed] [Google Scholar]
  6. Descos L., André F., André C., Gillon J., Landais P., Fermanian J. Assessment of appropriate laboratory measurements to reflect the degree of activity of ulcerative colitis. Digestion. 1983;28(2):148–152. doi: 10.1159/000198978. [DOI] [PubMed] [Google Scholar]
  7. EDWARDS F. C., TRUELOVE S. C. THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS. Gut. 1963 Dec;4:299–315. doi: 10.1136/gut.4.4.299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ekbom A., Helmick C., Zack M., Adami H. O. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet. 1990 Aug 11;336(8711):357–359. doi: 10.1016/0140-6736(90)91889-i. [DOI] [PubMed] [Google Scholar]
  9. Ekbom A., Helmick C., Zack M., Adami H. O. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med. 1990 Nov 1;323(18):1228–1233. doi: 10.1056/NEJM199011013231802. [DOI] [PubMed] [Google Scholar]
  10. Fireman Z., Grossman A., Lilos P., Hacohen D., Bar Meir S., Rozen P., Gilat T. Intestinal cancer in patients with Crohn's disease. A population study in central Israel. Scand J Gastroenterol. 1989 Apr;24(3):346–350. doi: 10.3109/00365528909093058. [DOI] [PubMed] [Google Scholar]
  11. Fozard J. B., Quirke P., Dixon M. F., Giles G. R., Bird C. C. DNA aneuploidy in ulcerative colitis. Gut. 1986 Dec;27(12):1414–1418. doi: 10.1136/gut.27.12.1414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gilat T., Fireman Z., Grossman A., Hacohen D., Kadish U., Ron E., Rozen P., Lilos P. Colorectal cancer in patients with ulcerative colitis. A population study in central Israel. Gastroenterology. 1988 Apr;94(4):870–877. doi: 10.1016/0016-5085(88)90541-0. [DOI] [PubMed] [Google Scholar]
  13. Greenstein A. J., Sachar D. B., Smith H., Janowitz H. D., Aufses A. H., Jr A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer. 1981 Dec 15;48(12):2742–2745. doi: 10.1002/1097-0142(19811215)48:12<2742::aid-cncr2820481231>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  14. Greenstein A. J., Sachar D. B., Smith H., Pucillo A., Papatestas A. E., Kreel I., Geller S. A., Janowitz H. D., Aufses A. H., Jr Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology. 1979 Aug;77(2):290–294. [PubMed] [Google Scholar]
  15. Gyde S. N., Prior P., Allan R. N., Stevens A., Jewell D. P., Truelove S. C., Lofberg R., Brostrom O., Hellers G. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut. 1988 Feb;29(2):206–217. doi: 10.1136/gut.29.2.206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gyde S. N., Prior P., Macartney J. C., Thompson H., Waterhouse J. A., Allan R. N. Malignancy in Crohn's disease. Gut. 1980 Dec;21(12):1024–1029. doi: 10.1136/gut.21.12.1024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hammarberg C., Rubio C., Slezak P., Tribukait B., Ohman U. Flow-cytometric DNA analysis as a means for early detection of malignancy in patients with chronic ulcerative colitis. Gut. 1984 Aug;25(8):905–908. doi: 10.1136/gut.25.8.905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hammarberg C., Slezak P., Tribukait B. Early detection of malignancy in ulcerative colitis. A flow-cytometric DNA study. Cancer. 1984 Jan 15;53(2):291–295. doi: 10.1002/1097-0142(19840115)53:2<291::aid-cncr2820530218>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  19. Kanemitsu T., Koike A., Yamamoto S. Study of the cell proliferation kinetics in ulcerative colitis, adenomatous polyps, and cancer. Cancer. 1985 Sep 1;56(5):1094–1098. doi: 10.1002/1097-0142(19850901)56:5<1094::aid-cncr2820560523>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  20. Katzka I., Brody R. S., Morris E., Katz S. Assessment of colorectal cancer risk in patients with ulcerative colitis: experience from a private practice. Gastroenterology. 1983 Jul;85(1):22–29. [PubMed] [Google Scholar]
  21. Korelitz B. I., Lauwers G. Y., Sommers S. C. Rectal mucosal dysplasia in Crohn's disease. Gut. 1990 Dec;31(12):1382–1386. doi: 10.1136/gut.31.12.1382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kvist N., Jacobsen O., Nørgaard P., Ockelmann H. H., Kvist H. K., Schou G., Jarnum S. Malignancy in Crohn's disease. Scand J Gastroenterol. 1986 Jan;21(1):82–86. doi: 10.3109/00365528609034627. [DOI] [PubMed] [Google Scholar]
  23. Löfberg R., Tribukait B., Ost A., Broström O., Reichard H. Flow cytometric DNA analysis in longstanding ulcerative colitis: a method of prediction of dysplasia and carcinoma development? Gut. 1987 Sep;28(9):1100–1106. doi: 10.1136/gut.28.9.1100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. McKinley M. J., Budman D. R., Kahn E. High grade dysplasia in Crohn's colitis characterized by flow cytometry. J Clin Gastroenterol. 1987 Aug;9(4):452–455. doi: 10.1097/00004836-198708000-00019. [DOI] [PubMed] [Google Scholar]
  25. Melville D. M., Jass J. R., Shepherd N. A., Northover J. M., Capellaro D., Richman P. I., Lennard-Jones J. E., Ritchie J. K., Andersen S. N. Dysplasia and deoxyribonucleic acid aneuploidy in the assessment of precancerous changes in chronic ulcerative colitis. Observer variation and correlations. Gastroenterology. 1988 Sep;95(3):668–675. doi: 10.1016/s0016-5085(88)80013-1. [DOI] [PubMed] [Google Scholar]
  26. Ransohoff D. F., Riddell R. H., Levin B. Ulcerative colitis and colonic cancer. Problems in assessing the diagnostic usefulness of mucosal dysplasia. Dis Colon Rectum. 1985 Jun;28(6):383–388. doi: 10.1007/BF02560215. [DOI] [PubMed] [Google Scholar]
  27. Riddell R. H., Goldman H., Ransohoff D. F., Appelman H. D., Fenoglio C. M., Haggitt R. C., Ahren C., Correa P., Hamilton S. R., Morson B. C. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983 Nov;14(11):931–968. doi: 10.1016/s0046-8177(83)80175-0. [DOI] [PubMed] [Google Scholar]
  28. Rutegård J., Ahsgren L., Stenling R., Roos G. DNA content in ulcerative colitis. Flow cytometric analysis in a patient series from a defined area. Dis Colon Rectum. 1988 Sep;31(9):710–715. doi: 10.1007/BF02552591. [DOI] [PubMed] [Google Scholar]
  29. Talstad I., Gjone E. The disease activity of ulcerative colitis and Crohn's disease. Scand J Gastroenterol. 1976;11(4):403–408. [PubMed] [Google Scholar]
  30. Terpstra O. T., van Blankenstein M., Dees J., Eilers G. A. Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer. Gastroenterology. 1987 Mar;92(3):704–708. doi: 10.1016/0016-5085(87)90021-7. [DOI] [PubMed] [Google Scholar]
  31. Thornthwaite J. T., Sugarbaker E. V., Temple W. J. Preparation of tissues for DNA flow cytometric analysis. Cytometry. 1980 Nov;1(3):229–237. doi: 10.1002/cyto.990010309. [DOI] [PubMed] [Google Scholar]
  32. Vindeløv L. L., Christensen I. J., Keiding N., Spang-Thomsen M., Nissen N. I. Long-term storage of samples for flow cytometric DNA analysis. Cytometry. 1983 Mar;3(5):317–322. doi: 10.1002/cyto.990030502. [DOI] [PubMed] [Google Scholar]
  33. Weedon D. D., Shorter R. G., Ilstrup D. M., Huizenga K. A., Taylor W. F. Crohn's disease and cancer. N Engl J Med. 1973 Nov 22;289(21):1099–1103. doi: 10.1056/NEJM197311222892101. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES